Journal: Archives of Toxicology
Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
doi: 10.1007/s00204-021-03187-w
Figure Lengend Snippet: Summary table of in vitro and in vivo mutagenicity/genotoxicity studies with graphene NPs
Article Snippet: 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. .
Techniques: In Vitro, In Vivo, Concentration Assay, Positive Control, Activation Assay, Negative Control, Control, Single Cell Gel Electrophoresis